← Back
Data updated: Mar 29, 2026
THERACOSBIO
MetabolicCardiovascular
Pharma
THERACOSBIO is a pharmaceutical company focused on Metabolic, Cardiovascular. Key products include BRENZAVVY.
2023
Since
1
Drugs
-
Trials
0
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Metabolic 95%
1 drugs Phase 3: 6 Phase 2: 1 Phase 1: 7
Cardiovascular 5%
0 drugs Phase 2: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2023-01-20
- Latest
- 2023-09-12
- Applications
- 1